Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin in Children With Proteinuric Chronic Kidney Disease
NCT04531397Phase 4Withdrawn
- Sponsor
- Children's Hospital of Fudan University
- Start
- Jan 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in chronic kidney disease (CKD), sponsored by Children's Hospital of Fudan University. Planned start Jan 2021; status: withdrawn.
02
Drugs
dapagliflozin
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT04531397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04531397.